Ulrich Naher - 08 Mar 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role: EVP, Chief Commercial Officer
Signature: Jonathan B. Leiken, Attorney in fact for Ulrich Naeher
Issuer symbol: DBD
Transactions as of: 08 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 10 Mar 2022, 15:29:52 UTC
Previous filing: 08 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DBD	Common Shares	Award	$0	+168,246	+84%	$0.000000	368,612	08 Mar 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	DBD	Non-Qualified Stock Options						49,650	08 Mar 2022	Common Shares	49,650	$26.60	Direct	F3
holding	DBD	Non-Qualified Stock Option						30,278	08 Mar 2022	Common Shares	30,278	$18.75	Direct	F4
holding	DBD	Non-Qualified Stock Option						47,407	08 Mar 2022	Common Shares	47,407	$4.08	Direct	F4
holding	DBD	Non-Qualified Stock Option						12,614	08 Mar 2022	Common Shares	12,614	$11.96	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award of restricted stock units; each restricted stock unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock.
F2	Number includes restricted stock units.
F3	Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F4	Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.